Anúncio
Anúncio

CRVO

CRVO logo

CervoMed Inc. Common Stock

7.79
USD
Patrocinado
-0.17
-2.08%
08 de jan., 15:54 UTC -5
Encerrado
exchange

Pós-Mercado

7.79

0.00
0.00%

Relatórios de Lucros CRVO

Rácio de surpresa positiva

CRVO separação 14 de 29 últimas estimativas.

48%

Próximo Relatório

Data do Próximo Relatório
16 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$986.00K
/
-$0.63
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+205.67%
/
-25.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-54.39%
/
-21.25%

CervoMed Inc. Common Stock earnings per share and revenue

On 07 de nov. de 2025, CRVO reported earnings of -0.84 USD per share (EPS) for Q3 25, missing the estimate of -0.78 USD, resulting in a -6.68% surprise. Revenue reached 322.57 mil, compared to an expected 1.45 milhão, with a -77.68% difference. The market reacted with a -0.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analistas forecast an EPS of -0.63 USD, with revenue projected to reach 986.00 mil USD, implying an diminuir of -25.00% EPS, and aumentar of 205.67% in Revenue from the last quarter.
FAQ
For Q3 2025, CervoMed Inc. Common Stock reported EPS of -$0.84, missing estimates by -6.68%, and revenue of $322.57K, -77.68% below expectations.
The stock price moved down -0.29%, changed from $6.92 before the earnings release to $6.90 the day after.
The next earning report is scheduled for 16 de mar. de 2026.
Based on 9 analistas, CervoMed Inc. Common Stock is expected to report EPS of -$0.63 and revenue of $986.00K for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio